Scientific Publications

A phase 1 safety study of SBP-101, a polyamine metabolic inhibitor, for pancreatic ductal adenocarcinoma (PDA).

View/download abstract »

AACR 2014 abstract #3128

Efficacy of Diethyldihydroxyhomospermine Against Human Pancreatic Adenocarcinoma Using Orthotopic Implantation of Human Pancreatic L3.6pl Cells into the Pancreas of Nude Mice

Shah AK, Cullen MT, Baker CH.

Poster Abstract